822 related articles for article (PubMed ID: 32315458)
1. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
[TBL] [Abstract][Full Text] [Related]
2. Interventions for the management of malignant pleural effusions: a network meta-analysis.
Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
[TBL] [Abstract][Full Text] [Related]
3. Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT.
Bhatnagar R; Luengo-Fernandez R; Kahan BC; Rahman NM; Miller RF; Maskell NA
Health Technol Assess; 2020 Jun; 24(26):1-90. PubMed ID: 32525474
[TBL] [Abstract][Full Text] [Related]
4. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.
Bhatnagar R; Piotrowska HEG; Laskawiec-Szkonter M; Kahan BC; Luengo-Fernandez R; Pepperell JCT; Evison MD; Holme J; Al-Aloul M; Psallidas I; Lim WS; Blyth KG; Roberts ME; Cox G; Downer NJ; Herre J; Sivasothy P; Menzies D; Munavvar M; Kyi MM; Ahmed L; West AG; Harrison RN; Prudon B; Hettiarachchi G; Chakrabarti B; Kavidasan A; Sutton BP; Zahan-Evans NJ; Quaddy JL; Edey AJ; Clive AO; Walker SP; Little MHR; Mei XW; Harvey JE; Hooper CE; Davies HE; Slade M; Sivier M; Miller RF; Rahman NM; Maskell NA
JAMA; 2020 Jan; 323(1):60-69. PubMed ID: 31804680
[TBL] [Abstract][Full Text] [Related]
5. Pleurodesis for malignant pleural effusions.
Shaw P; Agarwal R
Cochrane Database Syst Rev; 2004; (1):CD002916. PubMed ID: 14973997
[TBL] [Abstract][Full Text] [Related]
6. The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial.
Dipper A; Sundaralingam A; Hedley E; Tucker E; White P; Bhatnagar R; Moore A; Dobson M; Luengo-Fernandez R; Mills J; Sowden S; Harvey JE; Dobson L; Miller RF; Munavvar M; Rahman N; Maskell N
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37253535
[TBL] [Abstract][Full Text] [Related]
7. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
Davies HE; Mishra EK; Kahan BC; Wrightson JM; Stanton AE; Guhan A; Davies CW; Grayez J; Harrison R; Prasad A; Crosthwaite N; Lee YC; Davies RJ; Miller RF; Rahman NM
JAMA; 2012 Jun; 307(22):2383-9. PubMed ID: 22610520
[TBL] [Abstract][Full Text] [Related]
8. Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion.
Fitzgerald DB; Sidhu C; Budgeon C; Tan AL; Read CA; Kwan BCH; Smith NA; Fysh ET; Muruganandan S; Saghaie T; Shrestha R; Badiei A; Nguyen P; Burke A; Goddard J; Windsor M; McDonald J; Wright G; Czarnecka K; Sivakumar P; Yasufuku K; Feller-Kopman DJ; Maskell NA; Murray K; Lee YCG
Trials; 2022 Jun; 23(1):530. PubMed ID: 35761341
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial.
Bhatnagar R; Laskawiec-Szkonter M; Piotrowska HE; Kahan BC; Hooper CE; Davies HE; Harvey JE; Miller RF; Rahman NM; Maskell NA
BMJ Open; 2014 Nov; 4(11):e007045. PubMed ID: 25428632
[TBL] [Abstract][Full Text] [Related]
10. OPTIMUM: a protocol for a multicentre randomised controlled trial comparing Out Patient Talc slurry via Indwelling pleural catheter for Malignant pleural effusion vs Usual inpatient Management.
Sivakumar P; Douiri A; West A; Rao D; Warwick G; Chen T; Ahmed L
BMJ Open; 2016 Oct; 6(10):e012795. PubMed ID: 27798020
[TBL] [Abstract][Full Text] [Related]
11. Indwelling Pleural Catheter versus Pleurodesis for Malignant Pleural Effusions. A Systematic Review and Meta-Analysis.
Iyer NP; Reddy CB; Wahidi MM; Lewis SZ; Diekemper RL; Feller-Kopman D; Gould MK; Balekian AA
Ann Am Thorac Soc; 2019 Jan; 16(1):124-131. PubMed ID: 30272486
[TBL] [Abstract][Full Text] [Related]
12. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
13. Management of malignant pleural effusions.
Dipper A; Bhatnagar R; Maskell N
Curr Opin Pulm Med; 2020 Jul; 26(4):341-345. PubMed ID: 32487872
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14).
Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM
Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655
[TBL] [Abstract][Full Text] [Related]
15. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis.
Yeung M; Loh EW; Tiong TY; Tam KW
Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317
[TBL] [Abstract][Full Text] [Related]
16. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
Altmann ES; Crossingham I; Wilson S; Davies HR
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
[TBL] [Abstract][Full Text] [Related]
17. Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis.
Fysh ET; Thomas R; Read CA; Kwan BC; Yap E; Horwood FC; Lee P; Piccolo F; Shrestha R; Garske LA; Lam DC; Rosenstengel A; Bint M; Murray K; Smith NA; Lee YC
BMJ Open; 2014 Nov; 4(11):e006757. PubMed ID: 25377015
[TBL] [Abstract][Full Text] [Related]
18. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.
Muruganandan S; Azzopardi M; Fitzgerald DB; Shrestha R; Kwan BCH; Lam DCL; De Chaneet CC; Rashid Ali MRS; Yap E; Tobin CL; Garske LA; Nguyen PT; Stanley C; Popowicz ND; Kosky C; Thomas R; Read CA; Budgeon CA; Feller-Kopman D; Maskell NA; Murray K; Lee YCG
Lancet Respir Med; 2018 Sep; 6(9):671-680. PubMed ID: 30037711
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of indwelling pleural catheter placement versus placement plus talc sclerosant in patients with malignant pleural effusions managed exclusively as outpatients (IPC-PLUS): study protocol for a randomised controlled trial.
Bhatnagar R; Kahan BC; Morley AJ; Keenan EK; Miller RF; Rahman NM; Maskell NA
Trials; 2015 Feb; 16():48. PubMed ID: 25880969
[TBL] [Abstract][Full Text] [Related]
20. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
Tan C; Sedrakyan A; Browne J; Swift S; Treasure T
Eur J Cardiothorac Surg; 2006 May; 29(5):829-38. PubMed ID: 16626967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
